Boston Trust Walden Corp Acquires 6,216 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Boston Trust Walden Corp lifted its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 0.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 826,332 shares of the semiconductor company's stock after acquiring an additional 6,216 shares during the period. Boston Trust Walden Corp owned approximately 2.57% of Axcelis Technologies worth $41,044,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ACLS. Signaturefd LLC increased its position in Axcelis Technologies by 90.6% in the 4th quarter. Signaturefd LLC now owns 364 shares of the semiconductor company's stock valued at $25,000 after acquiring an additional 173 shares in the last quarter. Capital Advisors Ltd. LLC grew its position in shares of Axcelis Technologies by 1,415.2% during the 4th quarter. Capital Advisors Ltd. LLC now owns 500 shares of the semiconductor company's stock worth $35,000 after buying an additional 467 shares during the period. Fifth Third Bancorp grew its position in shares of Axcelis Technologies by 160.5% during the 1st quarter. Fifth Third Bancorp now owns 581 shares of the semiconductor company's stock worth $29,000 after buying an additional 358 shares during the period. Versant Capital Management Inc grew its position in shares of Axcelis Technologies by 118.7% during the 1st quarter. Versant Capital Management Inc now owns 584 shares of the semiconductor company's stock worth $29,000 after buying an additional 317 shares during the period. Finally, Smartleaf Asset Management LLC boosted its stake in Axcelis Technologies by 184.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 668 shares of the semiconductor company's stock worth $47,000 after acquiring an additional 433 shares during the last quarter. 89.98% of the stock is owned by institutional investors.

Insider Activity

In other news, Director John T. Kurtzweil sold 1,682 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $61.93, for a total value of $104,166.26. Following the completion of the transaction, the director now directly owns 35,050 shares in the company, valued at approximately $2,170,646.50. This trade represents a 4.58% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.48% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Separately, B. Riley lifted their price objective on shares of Axcelis Technologies from $58.00 to $75.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 18th. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $136.00.

Axcelis Technologies Price Performance

Shares of NASDAQ:ACLS traded up $0.51 during midday trading on Monday, hitting $66.53. The stock had a trading volume of 317,085 shares, compared to its average volume of 653,891. The company's 50-day moving average price is $57.47 and its 200-day moving average price is $61.29. The company has a market capitalization of $2.14 billion, a P/E ratio of 12.18, a price-to-earnings-growth ratio of 4.43 and a beta of 1.52. The company has a quick ratio of 4.08, a current ratio of 5.56 and a debt-to-equity ratio of 0.04. Axcelis Technologies, Inc. has a fifty-two week low of $40.40 and a fifty-two week high of $158.61.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last posted its earnings results on Tuesday, May 6th. The semiconductor company reported $1.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.65. Axcelis Technologies had a net margin of 18.58% and a return on equity of 18.55%. The firm had revenue of $192.56 million for the quarter, compared to analyst estimates of $184.86 million. During the same period in the previous year, the firm posted $1.57 EPS. The company's revenue for the quarter was down 23.7% compared to the same quarter last year. As a group, equities research analysts predict that Axcelis Technologies, Inc. will post 2.55 EPS for the current fiscal year.

Axcelis Technologies announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, March 12th that authorizes the company to buyback $100.00 million in shares. This buyback authorization authorizes the semiconductor company to repurchase up to 5.2% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board of directors believes its stock is undervalued.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.